Please check your internet connection and try again.
## Lorazepam (a representative benzodiazepine)
### Overview
Lorazepam is a benzodiazepine used for its sedative, anxiolytic, amnestic, and anticonvulsant properties.
### Primary Indications
* Anxiety disorders
* Insomnia due to anxiety
* Status epilepticus
* Preanesthetic medication
### Adult Dosing
* **Anxiety:** 1-4 mg orally every 8-12 hours as needed.
* **Insomnia:** 2-4 mg orally at bedtime.
* **Status Epilepticus:** 4 mg intravenously (IV) or intramuscularly (IM); an additional 4 mg may be given after 10-15 minutes if seizures persist. Higher doses may be required.
* **Preanesthetic Medication:** 2-4 mg IM or IV shortly before surgery.
### Pediatric Dosing
* **Status Epilepticus:**
* **Neonates:** 0.05 mg/kg IV/IM every 12-24 hours (use with extreme caution due to immature metabolism).
* **Children 5 years and older:** 0.05-0.1 mg/kg IV/IM, not to exceed 4 mg per dose, given slowly over 2-5 minutes. May repeat in 10-15 minutes.
* **Anxiety/Sedation:** Dosing is highly variable and typically initiated at low doses (e.g., 0.02-0.05 mg/kg/dose orally or IV) and titrated based on patient response. There is no established maximum dose in pediatrics and caution is advised.
### Dose Adjustments
* **Hepatic Impairment:** Use with caution; may require reduced doses.
* **Renal Impairment:** No specific dose adjustment is routinely recommended, but caution is advised.
* **Elderly:** Initiate at lower doses (e.g., 1-2 mg/day orally) and titrate slowly.
### Contraindications
* Known hypersensitivity to lorazepam, other benzodiazepines, or any component of the formulation.
* Acute narrow-angle glaucoma.
* Severe respiratory insufficiency.
* Severe hepatic insufficiency.
* Myasthenia gravis.
* Sleep apnea syndrome.
### Adverse Effects
* **Common:** Drowsiness, dizziness, weakness, unsteadiness.
* **Serious:** Respiratory depression (especially with IV administration or in combination with other CNS depressants), paradoxical reactions (e.g., excitation, agitation), amnesia, dependence and withdrawal symptoms.
### Key Drug Interactions
* **CNS Depressants (e.g., opioids, alcohol, other sedatives/hypnotics):** Additive CNS depression, increased risk of respiratory depression and sedation.
* **Theophyllines/Aminophylline:** May antagonize the sedative effects of lorazepam.
* **Valproic acid:** May increase lorazepam levels.
### Monitoring
* Respiratory rate, depth, and oxygen saturation, especially with parenteral administration.
* Level of consciousness and sedation.
* Signs of withdrawal if abruptly discontinued after prolonged use.
* Hepatic and renal function periodically.
### Clinical Pearls
* Intramuscular administration is generally well-absorbed.
* Intravenous lorazepam should be administered slowly to minimize respiratory depression and hypotension.
* Avoid abrupt discontinuation due to risk of withdrawal symptoms. Tapering doses is recommended.
* Pregnancy: Use only if clearly needed and the potential benefit justifies the potential risk to the fetus. Neonatal withdrawal symptoms can occur.
***
*Disclaimer: This information is intended for educational purposes only and does not constitute medical advice. Always consult the most current prescribing information and relevant clinical guidelines for definitive patient care decisions.*
